mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.007 |
mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.007 |
mRNA |
Bleomycin |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.008 |
mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.008 |
mRNA |
AZD7762 |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.009 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.009 |
mRNA |
NG-25 |
GDSC1000 |
pan-cancer |
AAC |
-0.077 |
0.01 |
mRNA |
KPT185 |
CTRPv2 |
pan-cancer |
AAC |
-0.099 |
0.01 |
mRNA |
linifanib |
GDSC1000 |
pan-cancer |
AAC |
-0.09 |
0.01 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.01 |